SCHEMBL3275975

SCHEMBL3275975

CC(C)(C)ON(C=O)CC1(CC(=O)OCCCCO[N+](=O)[O-])CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3277051 0.85
SCHEMBL3442430 0.76 CA12 (0.36)
SCHEMBL3277427 0.76 CA12 (0.40)
SCHEMBL13105649 0.75 USP2 (0.44)
SCHEMBL3278446 0.74 TMEM97 (0.30)
Hydrochloric Acid SCHEMBL3276629 0.74 USP2 (0.43)
SCHEMBL2295369 0.71
SCHEMBL13016826 0.63 ALDH1A1 (0.38)
SCHEMBL14697023 0.61 CA12 (0.46)
SCHEMBL23200526 0.60 PTGS2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7812039-B2 analgesic drug for treating neuropathic pain is selected from gabapentine, norvaline, pregabaline, (S)3-isobutylGABA, arginine, thiocitrulline, agmantine, vigabatrin etc. and a NO donar drugs belonging to the classes of aspirin, ibuprofen, paracetamol, naproxen, diclofenac or flurbiprofen NICOX S.A. (FR) 2010-10-12 US disclosed
US-7696230-B2 Drugs for chronic pains NICOX S.A. (FR) 2010-04-13 US disclosed
US-20080113950-A1 Drugs for chronic pains NICOX S.A. 2008-05-15 US disclosed
US-20070161576-A1 Drugs for chronic pains NICOX S.A. 2007-07-12 US disclosed
US-7199141-B2 Drugs for chronic pains NICOX S.A. (FR) 2007-04-03 US disclosed
US-20040171682-A1 Drugs for chronic pains NICOX S.A. (FR) 2004-09-02 US disclosed
EP-1417165-A2 DRUGS FOR CHRONIC PAINS Nicox S.A. (FR) 2004-05-12 EP disclosed
WO-2003000642-A2 DRUGS FOR CHRONIC PAINS NICOX S.A. (FR) 2003-01-03 WO disclosed